These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3876219)

  • 1. Pulmonary toxicity in mice after high-dose methotrexate administration with and without leucovorin rescue.
    Pesce C; Mansi C; Bogliolo G; Tobia F; Pannacciulli I
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):875-80. PubMed ID: 3876219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
    Sirotnak FM; Moccio DM; Dorick DM
    Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells.
    Pannacciulli I; Massa G; Bogliolo G; Ghio R; Sobrero A
    Cancer Res; 1982 Feb; 42(2):530-4. PubMed ID: 6976827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin.
    Motycka K; Slavík K; Balcarbová A; Cihar R; Spacek P; Kubín M
    Neoplasma; 1978; 25(2):217-25. PubMed ID: 306074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucovorin rescue of enteric lesions induced by high-dose methotrexate: a time-related study in mice.
    Mansi C; Pesce C; Gismondi C; Bogliolo G; Massa G; Celle G
    Tumori; 1986 Feb; 72(1):7-13. PubMed ID: 3485320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
    Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
    J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of delayed leucovorin "rescue" following high-dose methotrexate in children.
    Camitta BM; Holcenberg JS
    Med Pediatr Oncol; 1978; 5(1):55-9. PubMed ID: 370536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure.
    van den Bongard HJ; Mathĵt RA; Boogerd W; Schornagel JH; Soesan M; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):537-40. PubMed ID: 11459208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of methotrexate on spontaneous mammary adenocarcinomata in female C3H mice.
    Shewell J
    Br J Cancer; 1976 Feb; 33(2):210-6. PubMed ID: 1083245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice.
    Heppner GH; Calabresi P
    Cancer Res; 1977 Dec; 37(12):4580-3. PubMed ID: 303542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. l-5-formyltetrahydrofolate and l-5-methyltetrahydrofolate rescue in L1210 leukemia treated with high methotrexate doses.
    Simile MM; DeMiglio MR; Nufris A; Pascale RM; Muroni MR; Feo F
    Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):251-4. PubMed ID: 8210704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
    Pinedo HM; Zaharko DS; Bull JM; Chabner BA
    Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of leucovorin rescue to prevent reactivation of a solar burn after high dose methotrexate.
    Corder MP; Stone WH
    Cancer; 1976 Apr; 37(4):1660-2. PubMed ID: 1083286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vincristine in the etiology of toxicity of high-dose methotrexate therapy.
    Ridgway D; Renholds DC; Neerhout RC; Wolff LJ
    Cancer; 1980 Dec; 46(12):2571-2. PubMed ID: 6969624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of methotrexate toxicity in mice by a calcium salt of citrovorum factor and related compounds.
    Temple C; Rose JD; Laster WR; Montgomery JA
    Cancer Treat Rep; 1981; 65(11-12):1117-9. PubMed ID: 6975166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of methotrexate administration following 5-fluorouracil.
    White RM
    Am J Clin Oncol; 1996 Oct; 19(5):492-9. PubMed ID: 8823478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
    Goorin A; Strother D; Poplack D; Letvak LA; George M; Link M
    Med Pediatr Oncol; 1995 Jun; 24(6):362-7. PubMed ID: 7715542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
    Buckley LM; Vacek PM; Cooper SM
    J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.